The effect of azithromycin 1 on the signs and symptoms of blepharitis

The effect of a 1% azithromycin eye drops treatment on signs and symptoms of blepharitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190618043934N9

Enrollment

Registered

2021-04-14

Start date

2021-04-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blepharitis. Blepharitis

Interventions

Intervention 1: Intervention group: Patients receiving azithromycin 1% eye drops (manufactured by Sina Daru Pharmaceutical Company-Iran) topically twice a day for 4 days. Intervention 2: Control group

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with anterior blepharitis Age 18 to 80 years

Exclusion criteria

Exclusion criteria: Eye injuries and infections Non-dry eye inflammation, surgery Eye trauma in the last 6 months

Design outcomes

Primary

Measure	Time frame
Clinical signs and symptoms of blepharitis include eye irritation, itching and burning of the eyelids, eye discomfort after working with a computer, a feeling of heaviness in the eyelids, discharge on the eyelashes, a feeling of dry eyes, sticking of the eyelids when waking up and redness of the eyes. Timepoint: Before and after the intervention (4 weeks after the intervention). Method of measurement: Self-reported using the standard OcularSurfaceDiseaseIndex questionnaire.	—

Measure

Time frame

Clinical signs and symptoms of blepharitis include eye irritation, itching and burning of the eyelids, eye discomfort after working with a computer, a feeling of heaviness in the eyelids, discharge on the eyelashes, a feeling of dry eyes, sticking of the eyelids when waking up and redness of the eyes. Timepoint: Before and after the intervention (4 weeks after the intervention). Method of measurement: Self-reported using the standard OcularSurfaceDiseaseIndex questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZabihullah Mohaghegh

Birjand University of Medical Sciences

oabstudent@gmail.com+98 56 3232 3232

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026